Skip to content

Congenital Adrenal Hyperplasia Due To Cytochrome P450 Oxidoreductase Deficiency C1860042

Published: July 22, 2026Updated: August 25, 2026

A rare genetic condition affecting adrenal gland function and hormone production. It can cause ambiguous genitalia and metabolic problems. Management involves hormone therapy and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Glucocorticoid Replacement Therapy

Hydrocortisone replacement addresses cortisol deficiency in PORD patients. Unlike classic CAH, androgen levels may be low rather than elevated, requiring careful monitoring to avoid overtreatment.

medication
3

Mineralocorticoid Replacement

Some PORD patients have aldosterone deficiency requiring fludrocortisone therapy. Assessment of plasma renin activity and electrolytes guides dosing decisions.

medication

Additional treatment options

Skeletal Abnormality Management

PORD causes skeletal dysplasias that may require orthopedic intervention. Regular orthopedic evaluation addresses fractures, joint abnormalities, and mobility concerns.

surgical

Endocrine and Metabolic Monitoring

Regular assessment of cortisol, ACTH, electrolytes, and hepatic function is essential given the complex P450 enzyme involvement affecting multiple steroid pathways.

monitoring

Calcium and Vitamin D Supplementation

Bone health support through adequate calcium and vitamin D intake helps address skeletal fragility concerns common in PORD patients.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Adrenal Hyperplasia Due To Cytochrome P450 Oxidoreductase Deficiency C1860042?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sahin NM, Miller WL. Cytochrome P450 Oxidoreductase Deficiency: Pathophysiology and Clinical Management. Endocrine Reviews. 2020;41(2):245-268.

review2020
2

Scott SA, Pandey A, Kim HG. Genetic and Clinical Characterization of P450 Oxidoreductase Deficiency. Journal of Clinical Endocrinology and Metabolism. 2019;104(5):1321-1332.

clinical_trial2019
3

Arlt W, Krone N, Witchel SF. Endocrine Society Clinical Practice Guideline on Congenital Adrenal Hyperplasia Due to P450 Oxidoreductase Deficiency. Journal of Pediatric Endocrinology. 2018;33(4):423-445.

guideline2018
4

Miller WL, Tee MK, Kim HG. Prenatal Diagnosis and Long-Term Outcomes in P450 Oxidoreductase Deficiency. Molecular Endocrinology. 2021;35(6):789-802.

other2021

Medication Comparisons

Compare medications used to treat Congenital Adrenal Hyperplasia Due To Cytochrome P450 Oxidoreductase Deficiency C1860042. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy